Car Sales Still Spe...
Health Care: Drugs
Accelr8 Technology Corporation (AXK: AMEX)
$3.48 0.81 | 30.34%
06/01/12 - 04:03 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 173.50 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | n.a. | 12.50 |
| Beta | 1.17 | 0.96 | 0.98 |
| Price to Sales (TTM) | 70.05 | 4.16 | 1.42 |
| Price to Book (MRQ) | 8.88 | 3.92 | 2.41 |
| Price to Tangible Book (MRQ) | 23.28 | 5.44 | 5.08 |
| Price to Cash Flow (TTM) | -42.20 | 46.50 | 9.80 |
| Price to Free Cash Flow (TTM) | n.a. | -315.20 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.30 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.30 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 35.82 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 63.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | -97.30 | 6.80 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -50.10 | -3.40 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 41.60 | 0.00 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | -93.00 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | -93.00 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | n.a. | -9.04 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 4.80 | 2.90 | 1.10 |
| Current Ratio (MRQ) | 5.10 | 3.60 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.04 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.09 | 0.96 |
| Interest Coverage (TTM) | n.a. | 22.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | n.a. | 62.80 | 46.90 |
| Gross Margin - 5 Yr Avg | 98.70 | 63.90 | 47.70 |
| EBITD Margin (TTM) | n.a. | 15.20 | 18.90 |
| EBITD - 5 Yr Avg | -137.84 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | n.a. | 8.80 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | -76.60 | -0.50 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -2.13 | 0.03 | 0.09 |
| Net Profit Margin - 5 Yr Avg | -76.60 | -6.20 | 7.00 |
| Return on Assets (TTM) | -19.50 | 1.90 | 3.10 |
| Return on Assets - 5 Yr Avg | -13.60 | -4.20 | 2.50 |
| Return on Investment (TTM) | -27.00 | 2.40 | 7.90 |
| Return on Investment - 5 Yr Avg | -17.70 | -5.80 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 68,947.00 | 229,628.00 | 449,376.00 |
| Net Income/Employee (TTM) | -146,639.00 | 6,227.00 | 39,003.00 |
| Receivable Turnover (TTM) | 1.10 | 7.10 | 7.60 |
| Inventory Turnover (TTM) | 0.00 | 3.00 | 8.30 |
| Asset Turnover (TTM) | 0.10 | 0.70 | 0.40 |
Portfolios with AXK
- Portfolio NameUser Type
- ContributorBest-Performing Stocks Unde...
- Contributor10 Best-Performing Stocks U...
- Contributor10 Best-Performing Stocks U...
- UserMary
- UserBerridge Investments
- Userlaredo Portfolio 1
- Usergenomiks BIOMED
- UserPANTERA GROUP 169(SUPRATRADE)
- UserBenitrans GStock II
- UserCharles
Latest AXK Headlines from TheStreet
- Accelr8 Technology Corporation Stock Downgraded (AXK) 11.02.11 | 07:11 am
- Accelr8 Technology Stock Soars (AXK) 10.12.11 | 10:10 am
- Accelr8 Technology Stock Soars (AXK) 10.05.11 | 02:10 pm
- Best-Performing Stocks Under $5 in 2011 09.28.11 | 01:09 pm
- Best-Performing Stocks Under $5 in 2011 08.31.11 | 06:08 am
- Accelr8 Technology Stock Gaps Up On Today's Open (AXK) 06.30.11 | 10:06 am
- Accelr8 Technology Stock Soars (AXK) 06.22.11 | 02:06 pm
- Accelr8 Technology Stock Soars (AXK) 06.09.11 | 10:06 am
- 10 Best-Performing Stocks Under $5 This Year 04.27.11 | 06:04 am
- 10 Best-Performing Stocks Under $5 This Year 03.30.11 | 07:03 am
Press Releases for AXK
- Accelr8 Attracts Up To $35 Million Private Equity Investment - Business Wire 04.23.12 | 03:04 pm
- Accelr8 Announces Interim Plan And Advanced Studies - Business Wire 10.13.11 | 07:10 am
- Accelr8 Announces Renewal And Expansion Of SCHOTT Microarray License, And Notice Of Allowance For New Patent - Business Wire 09.22.11 | 08:09 am
- Accelr8 Announces Results In Award-Winning Presentation For Rapid Diagnostics With ICU Specimens - Business Wire 09.19.11 | 10:09 am
- Accelr8 Announces Continuation And Expansion Of BACcel™ Development Collaboration - Business Wire 07.25.11 | 08:07 am
- Accelr8 To Receive Award For ICAAC Presentation - Business Wire 07.18.11 | 07:07 am
- Accelr8 Announces Continuation Of BACcel™ Collaboration - Business Wire 06.30.11 | 05:06 pm
- Accelr8 States That Its Policy Is Not To Comment On Unusual Market Activity Or Rumors - Business Wire 06.09.11 | 11:06 am
- Accelr8 4-Hour Test Identifies New Drug-Resistant “Staph” (hVISA) Undetectable By Hospital Labs - Business Wire 05.23.11 | 07:05 am
- Accelr8 States That Its Policy Is Not To Comment On Unusual Market Activity Or Rumors - Business Wire 05.19.11 | 05:05 pm
Partner Headlines for AXK
- Accelr8 Technology Corp: Invest At Your Own Risk - Seeking Alpha 06.24.11 | 09:06 am
